Gerben A. Koning

6.8k total citations
98 papers, 5.5k citations indexed

About

Gerben A. Koning is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Gerben A. Koning has authored 98 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 46 papers in Biomaterials and 35 papers in Biomedical Engineering. Recurrent topics in Gerben A. Koning's work include Nanoparticle-Based Drug Delivery (46 papers), RNA Interference and Gene Delivery (33 papers) and Nanoplatforms for cancer theranostics (24 papers). Gerben A. Koning is often cited by papers focused on Nanoparticle-Based Drug Delivery (46 papers), RNA Interference and Gene Delivery (33 papers) and Nanoplatforms for cancer theranostics (24 papers). Gerben A. Koning collaborates with scholars based in Netherlands, France and Germany. Gerben A. Koning's co-authors include Timo L.M. ten Hagen, Gert Storm, Alexander Eggermont, Enrico Mastrobattista, Lars H. Lindner, Wim E. Hennink, Daan J.A. Crommelin, Bilyana M. Dicheva, Ann L.B. Seynhaeve and Gerard C. van Rhoon and has published in prestigious journals such as Journal of Biological Chemistry, Nano Letters and The Journal of Immunology.

In The Last Decade

Gerben A. Koning

96 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerben A. Koning Netherlands	43	2.9k	2.5k	2.1k	758	548	98	5.5k
J. Strohalm Czechia	40	2.2k 0.8×	2.7k 1.1×	1.3k 0.6×	762 1.0×	868 1.6×	90	5.2k
Samuel Zalipsky United States	42	3.9k 1.4×	3.3k 1.3×	1.5k 0.7×	914 1.2×	614 1.1×	60	6.7k
Matthew R. Dreher United States	42	1.7k 0.6×	2.4k 0.9×	2.5k 1.2×	931 1.2×	660 1.2×	87	6.3k
Daryl C. Drummond United States	41	4.4k 1.5×	3.7k 1.5×	2.2k 1.1×	1.1k 1.5×	1.4k 2.5×	102	8.0k
Priya Karmali United States	28	2.8k 1.0×	1.6k 0.6×	1.2k 0.6×	319 0.4×	565 1.0×	50	4.6k
Tomáš Etrych Czechia	46	2.4k 0.8×	4.0k 1.6×	2.7k 1.3×	583 0.8×	717 1.3×	217	6.7k
Christopher P. Leamon United States	43	3.2k 1.1×	1.7k 0.7×	1.3k 0.6×	1.1k 1.4×	1.7k 3.2×	94	6.6k
Venkata Ramana Kotamraju United States	36	3.7k 1.3×	2.3k 0.9×	2.2k 1.1×	654 0.9×	1.1k 1.9×	51	6.4k
Tambet Teesalu Estonia	46	4.3k 1.5×	2.1k 0.8×	2.1k 1.0×	757 1.0×	1.2k 2.2×	119	7.4k
James P. Basilion United States	38	2.2k 0.8×	1.1k 0.4×	1.7k 0.8×	585 0.8×	407 0.7×	84	5.3k

Countries citing papers authored by Gerben A. Koning

Since Specialization

Citations

This map shows the geographic impact of Gerben A. Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerben A. Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerben A. Koning more than expected).

Fields of papers citing papers by Gerben A. Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerben A. Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerben A. Koning. The network helps show where Gerben A. Koning may publish in the future.

Co-authorship network of co-authors of Gerben A. Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Gerben A. Koning. A scholar is included among the top collaborators of Gerben A. Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerben A. Koning. Gerben A. Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cappellen, Wiggert A. van, Barbara Steurer, Timo L.M. ten Hagen, et al.. (2015). C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(8). 1656–1670. 6 indexed citations

Zalba, Sara, Azadeh Haeri, Timo L.M. ten Hagen, et al.. (2015). Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer. Journal of Controlled Release. 210. 26–38. 96 indexed citations

Hossann, Martin, Kirsten Wachholz, Timo L.M. ten Hagen, et al.. (2015). Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors. Journal of Controlled Release. 222. 47–55. 49 indexed citations

Kam, Boen L.R., Gerben A. Koning, Mark Konijnenberg, et al.. (2014). [ ¹¹¹ In-DTPA]octreotide Tumor Uptake in GEPNET Liver Metastases After Intra-Arterial Administration: An Overview of Preclinical and Clinical Observations and Implications for Tumor Radiation Dose After Peptide Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 29(4). 179–187. 23 indexed citations

Hagen, Timo L.M. ten, Regine Süss, Albert J. van Hell, et al.. (2014). Short-Chain Glycoceramides Promote Intracellular Mitoxantrone Delivery from Novel Nanoliposomes into Breast Cancer Cells. Pharmaceutical Research. 32(4). 1354–1367. 14 indexed citations

Seynhaeve, Ann L.B., Bilyana M. Dicheva, Saske Hoving, Gerben A. Koning, & Timo L.M. ten Hagen. (2013). Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: Evaluated by in vitro / in vivo live cell imaging. Journal of Controlled Release. 172(1). 330–340. 131 indexed citations

Li, Li, Timo L.M. ten Hagen, Azadeh Haeri, et al.. (2013). A novel two-step mild hyperthermia for advanced liposomal chemotherapy. Journal of Controlled Release. 174. 202–208. 73 indexed citations

Manzoor, Ashley A., Lars H. Lindner, Chelsea D. Landon, et al.. (2012). Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors. Cancer Research. 72(21). 5566–5575. 375 indexed citations

Hagen, Timo L.M. ten, Wim C.J. Hop, Herman van Dekken, et al.. (2012). Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer. European Journal of Cancer. 49(2). 323–328. 4 indexed citations

10.

Koning, Gerben A. & Gerard C. Krijger. (2007). Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery. Anti-Cancer Agents in Medicinal Chemistry. 7(4). 425–440. 66 indexed citations

11.

Schubert, Rolf, Ronald S. Oosting, Enrico Mastrobattista, et al.. (2007). Cellular Uptake of Cationic Polymer-DNA Complexes Via Caveolae Plays a Pivotal Role in Gene Transfection in COS-7 Cells. Pharmaceutical Research. 24(8). 1590–1598. 205 indexed citations

12.

Seppenwoolde, Jan‐Henry, Vanessa Mateus, Chris J.G. Bakker, et al.. (2006). Lanthanide-Loaded Liposomes for Multimodality Imaging and Therapy. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 520–527. 42 indexed citations

13.

Mulder, Willem J. M., Kim Douma, Gerben A. Koning, et al.. (2006). Liposome‐enhanced MRI of neointimal lesions in the ApoE‐KO mouse. Magnetic Resonance in Medicine. 55(5). 1170–1174. 45 indexed citations

14.

Venkateswarlu, Vobalaboina, et al.. (2006). Radioprotective effect of transferrin targeted citicoline liposomes. Journal of drug targeting. 14(1). 13–19. 15 indexed citations

15.

Koning, Gerben A., et al.. (2005). Covalent attachment of an NLS-peptide to linear dna does not enhance transfection efficiency of cationic polymer based gene delivery systems.. PubMed. 101(1-3). 395–7. 12 indexed citations

16.

Veldman, Robert Jan, Gerben A. Koning, Albert J. van Hell, et al.. (2005). Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin. Journal of Pharmacology and Experimental Therapeutics. 315(2). 704–710. 29 indexed citations

17.

Fretz, Marjan M., Enrico Mastrobattista, Gerben A. Koning, Wim Jiskoot, & Gert Storm. (2005). Strategies for cytosolic delivery of liposomal macromolecules. International Journal of Pharmaceutics. 298(2). 305–309. 29 indexed citations

18.

Fretz, Marjan M., Gerben A. Koning, Enrico Mastrobattista, Wim Jiskoot, & Gert Storm. (2004). OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1665(1-2). 48–56. 91 indexed citations

19.

Everts, Maaike, Robbert J. Kok, Sigrídur A. Ásgeirsdóttir, et al.. (2002). Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate. The Journal of Immunology. 168(2). 883–889. 73 indexed citations

20.

Koning, Gerben A., Henriëtte W. M. Morselt, Maria Velinova, et al.. (1999). Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1420(1-2). 153–167. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact